Minor
BRAMLIE · AMX-883 Alone · AML and High-risk MDS and in Combination in Participants With AML
Start date changed from estimate of Oct 16, 2026 to Sep 16, 2026
And 1 more change in the last 30 days
Amphista Therapeutics LtdPhase 1 NCT07723703 Registry history of NCT07723703 on ClinicalTrials.gov (opens the registry)